Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

Clinical trial NCT05059327 · COMPLETED

Trial details

NCT number: NCT05059327
Sponsor: Noema Pharma AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberous Sclerosis Complex

Start date: 2022-03-03
Primary completion: 2025-02-06
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.